Bosh sahifaHKMPF • OTCMKTS
add
Hikma Pharmaceuticals Plc
Yopilish kursi
22,56 $
Yillik diapazon
21,90 $ - 26,50 $
Bozor kapitalizatsiyasi
4,33 mlrd GBP
Oʻrtacha hajm
28,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
LON
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 784,50 mln | 9,95% |
Joriy xarajat | 177,00 mln | -12,81% |
Sof foyda | 113,00 mln | 72,52% |
Sof foyda marjasi | 14,40 | 56,86% |
Har bir ulushga tushum | — | — |
EBITDA | 249,50 mln | 11,88% |
Amaldagi soliq stavkasi | 20,49% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 260,00 mln | -11,56% |
Jami aktivlari | 4,85 mlrd | 4,94% |
Jami passivlari | 2,55 mlrd | 5,38% |
Umumiy kapital | 2,30 mlrd | — |
Tarqatilgan aksiyalar | 221,75 mln | — |
Narxi/balansdagi bahosi | 2,19 | — |
Aktivlardan daromad | 10,37% | — |
Kapitaldan daromad | 14,05% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 113,00 mln | 72,52% |
Operatsiyalardan naqd pul | 99,00 mln | -10,81% |
Sarmoyadan naqd pul | -53,00 mln | 10,92% |
Moliyadan naqd pul | -26,00 mln | 46,94% |
Naqd pulning sof oʻzgarishi | 15,50 mln | 1 450,00% |
Boʻsh pul | 116,38 mln | 10,50% |
Haqida
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index. Wikipedia
Tashkil etilgan
1978
Sayt
Xodimlar soni
9 100
